Elham Armah
Nurse Practitioner · Jonesboro, ARNPI 1851718381
Payments from drug & device makers
Across 55 payments — averaging $60.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$679
- GSK$291
- Amgen$278
- Axsome Therapeutics, Inc.$270
- AbbVie$233
- Merck$156
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,318100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $679 |
| GSK | 3 | $291 |
| Amgen | 4 | $278 |
| Axsome Therapeutics, Inc. | 3 | $270 |
| AbbVie | 4 | $233 |
| Merck | 8 | $156 |
| Abbott | 1 | $146 |
| Johnson & Johnson | 3 | $135 |
| Lilly USA, LLC | 3 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Neurocrine Biosciences, Inc. | 2 | $112 |
| Viiv Healthcare Company | 3 | $110 |
| Impel Pharmaceuticals Inc. | 2 | $97 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $93 |
| EMD Serono, Inc. | 1 | $91 |
| Sanofi-aventis U.S. LLC | 1 | $90 |
| Lundbeck LLC | 1 | $90 |
| Neurelis, Inc. | 1 | $88 |
| Genentech USA, Inc. | 1 | $86 |
| Mission Pharmacal Company | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$146
- Austedo XR$122
- UBRELVY$112
- AREXVY$101
How this compares
$3,318 in reported general payments places this provider in the 85th percentile of 697 nurse practitioner providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 30 | $38,301 |
| Atorvastatin Calcium | 24 | $150 |
| Lisinopril | 14 | $149 |
| Solifenacin Succinate | 13 | $115 |
| Pantoprazole Sodium | 20 | $113 |
| Metformin Hcl | 20 | $92 |
| Cyclobenzaprine Hcl | 13 | $74 |
| Meloxicam | 18 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $125 | $38,30130 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 697 nurse practitioner providers in Arkansas.
Other nurse practitioner in Jonesboro
- Angela JonesJonesboro$90K
- Rhonda HillJonesboro$20K
- Mandy GordonJonesboro$12K
- Kirk WilliamsonJonesboro$8K
- Brooke PruittJonesboro$7K
- Mary OharaJonesboro$6K
- Angie HolifieldJonesboro$4K
- Merideth HanksRogers$157K
- Tiffany McConathyHot Springs$54K
- Brenna FitzgeraldNorth Little Rock$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.